Alpha Cancer Technologies (aka ACT)

A proprietary drug delivery platform that uses human Alpha-Fetoprotein (AFP) to deliver selective chemotherapy, avoiding damage to normal cells

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Alpha Cancer Technologies (aka ACT) plus 5056 other startups.

Start Free 7 Day Trial Now

Learn More About Alpha Cancer Technologies (aka ACT)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Our Clients